Heliox ventilation promotes pulmonary circulation and cardiac function in elderly hypertensive patients: a randomized controlled trial.
Lili Zhou, Lihui Chen, Jing Lin et al.
✦ AI-curated · Sources linked
In 30 seconds
This randomized controlled study compared heliox with conventional nitrogen–oxygen ventilation in 40 elderly hypertensive patients requiring invasive mechanical ventilation in an intensive care unit. Twenty patients per group received the assigned ventilation protocol for 3 hours. Compared with nitrogen–oxygen ventilation, heliox was associated with lower central venous pressure and higher central venous oxygen saturation, alongside elevated plasma nitric oxide. Endothelin-1 did not differ significantly between groups. The authors interpret these findings as evidence that heliox may improve cardiac function by promoting pulmonary circulation and vasodilation.
Key findings
- The trial included 40 patients, randomly assigned to heliox or nitrogen–oxygen ventilation, with 20 patients in each group.
- After the 3-hour protocol, the heliox group had lower central venous pressure and higher central venous oxygen saturation than the nitrogen–oxygen group.
- Plasma nitric oxide was higher with heliox; endothelin-1 levels did not differ significantly between groups.
Why it matters
The findings suggest that ventilation gas composition may influence pulmonary circulation and cardiac-function indicators in elderly hypertensive patients receiving invasive ventilation. The observed changes in central venous pressure, oxygen saturation, and nitric oxide provide a physiological signal that may inform further evaluation of heliox in this setting, but do not establish effects on patient-centred outcomes.
What to keep in mind
The study was small, conducted at a single intensive care unit, and assessed outcomes after a 3-hour ventilation protocol; the abstract reports no patient-centred outcomes.